Status:
COMPLETED
The Effect of Ischaemic-Reperfusion in Man - A Bradykinin Dependent Pathway
Lead Sponsor:
University of Edinburgh
Collaborating Sponsors:
University of Aarhus
University of Oxford
Conditions:
Ischaemic Heart Diseases
Eligibility:
MALE
18-65 years
Phase:
NA
Brief Summary
Heart attacks are usually caused by a blood clot blocking an artery supplying blood to the heart. Current treatments are designed to relieve this blockage as quickly as possible to minimize damage to ...
Eligibility Criteria
Inclusion
- healthy males between 18-65 years of ages
- non-smokers
Exclusion
- any concurrent illness or chronic medical condition
- concurrent use of vasoactive medication
- smoking history
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2010
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00965120
Start Date
August 1 2009
End Date
October 1 2010
Last Update
October 25 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Edinburgh, 49 Little France Crescent
Edinburgh, United Kingdom, EH16 4SB